Contraindicated. Coadministration of doravirine with a robust CYP3A inducer could reduce doravirine plasma concentrations and/or effects. Prospective for loss of virologic reaction and possible resistance to doravirine.Soon after stopping a CYP3A4 inducer, because the effects in the inducer decrease, the fentanyl plasma focus will maximize which co